Eli Lilly 2007 Annual Report Download - page 93

PROXY STATEMENT
9191
ment incentive, benefi t, and perquisite programs. Management has the primary responsibility for the company’s
fi nancial statements and reporting process, including the disclosure of executive compensation. With this in mind,
we have reviewed and discussed with management the Compensation Discussion and Analysis found on pages
81–90 of this proxy statement. The committee is satisfi ed that the Compensation Discussion and Analysis fairly and
completely represents the philosophy, intent, and actions of the committee with regard to executive compensa-
tion. We recommended to the board of directors that the Compensation Discussion and Analysis be included in this
proxy statement for fi ling with the Securities and Exchange Commission.
Compensation Committee
Karen N. Horn, Ph.D., Chair
George M.C. Fisher
J. Erik Fyrwald
Ellen R. Marram
Summary Compensation Table 1
Name and Principal
Position Year
Salary
($)
Stock Awards2
($)
Option Awards2
($)
Non-Equity
Incentive Plan
Compensation3
($)
Change in
Pension Value4
($)
All Other
Compensation5
($)
Total
Compensation
($)
Sidney Taurel
Chairman of the Board and
Chief Executive Offi cer
2007
2006 $1,717,417 $1,650,333 $6,443,000 $5,400,000 $600,000 $3,805,333 $4,035,929 $2,764,308 0 $1,417,434 $215,044 $192,409 $13,011,390 $15,229,817
John C. Lechleiter, Ph.D.
President and Chief
Operating Offi cer
2007
2006 $1,149,083 $1,112,000 $4,641,000 $3,510,000 $390,000 $3,967,976 $2,160,277 $1,490,080 $921,394 $1,156,247 $70,761 $68,790 $9,332,515 $11,305,093
Steven M. Paul, M.D.
Executive Vice President,
Science and Technology
2007
2006 $960,333 $916,167 $2,852,671 $1,864,460 $200,000 $1,240,000 $1,534,613 $1,043,514 $396,687 $607,463 $13,500 $55,789 $5,957,804 $5,727,393
Robert A. Armitage
Senior Vice President and
General Counsel
2007
2006 $741,667 $701,657 $1,995,000 $1,394,053 $716,400 $1,339,911 $1,045,750 $705,165 $232,697 $231,862 $45,551 $42,691 $4,777,065 $4,415,339
Derica W. Rice
Senior Vice President and
Chief Financial Offi cer
2007
2006 $747,583 $615,000 $1,995,000 $675,000 $473,675 $590,928 $1,054,093 $580,466 $194,469 $168,627 $78,787 $37,722 $4,543,607 $2,667,743
1 No bonus was paid to a named executive offi cer except as part of a non-equity incentive plan.
2 No stock options were granted in 2007. A discussion of the assumptions used in calculating these values may be
found in Note 7 to our 2007 audited fi nancial statements on pages 43–44 of our annual report.
3 Payment for 2007 performance made in March 2008 under the Eli Lilly and Company Bonus Plan.
4
The amounts in this column are the change in pension value for each individual. No named executive offi cer received
preferential or above-market earnings on deferred compensation.
5 The table below shows the components of this column for 2007, which include the company match for each individ-
ual’s savings plan contributions, tax reimbursements, and perquisites.
Name Year Savings Plan Match Tax Reimbursements Perquisites Other
Total “All Other
Compensation”
Mr. Taurel 2007
2006 $103,045 $99,020 $2,7311
$1,3821 $109,2684
$92,00740
0$215,044 $192,409
Dr. Lechleiter 2007
2006 $68,945 $66,720 $1,8162
$2,07020
00 0$70,761 $68,790
Dr. Paul 2007
2006 $13,500 $54,970 0 $8192 0
00 0$13,500 $55,789
Mr. Armitage 2007
2006 $44,500 $42,099 $1,0512
$59220
00 0$45,551 $42,691
Mr. Rice 2007
2006 $44,855 $36,900 $15,0302,3
$82220
0$18,9025
0$78,787 $37,722
1 Tax reimbursements on income imputed to Mr. Taurel for his use of the corporate aircraft to attend outside
board meetings and for travel by his wife on the corporate aircraft to attend certain company functions in-
volving spouse participation.